PRESS RELEASE – OREGA announces licensing of CD39 Program to Innate Pharma
17 January 2016
Jeremy Bastid, CEO, will attend the 2026 SITC EU Immuno-Oncology Drug Development Summit to be held on sept. 3 & 4, 2026 in Lausanne, Switzerland at the Agora Cancer Research Center.
